Long circulating nanocarriers: achievements and shortcomings of biomimetic approaches.

Adequate longevity in the systemic circulation is a prerequisite for many nanocarriers to fulfill their entrusted mission, be it an extended release of the incorporated drug or targeting of certain cells or tissues. This is, however, majorly challeng…

Preview only. Read the full abstract at the source